PET device company Positron has entered an agreement to acquire 510(k) marketing and manufacturing clearance rights in the U.S. from Neusoft Medical Systems for its NeuSight PET/CT scanner.
Gaining the 510(k) clearance from Neusoft enables Positron to add a PET/CT scanner to its product line, with PET/CT imaging at the forefront of oncology studies and vital in nuclear cardiology, the vendor noted. Details of the deal were undisclosed.
The NeuSight PET/CT scanner was developed by Neusoft subsidiary Shenyang Intelligent Neuclear Medical Technology Company.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
